Stock 8SJ SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shanghai Junshi Biosciences Co., Ltd. Deutsche Boerse AG

Equities

8SJ

CNE100003FF7

Delayed Deutsche Boerse AG
Other stock markets
 09:29:01 2024-06-04 EDT 		5-day change 1st Jan Change
1.37 EUR +3.79% Intraday chart for Shanghai Junshi Biosciences Co., Ltd. +7.03% -47.31%
04-29 Shanghai Junshi Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Shanghai Junshi Biosciences Receives Hong Kong Approval for Cancer Drug Toripalimab MT

Evolution of the average Target Price on Shanghai Junshi Biosciences Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

c348db34b6969f9c7dcf96918fc.GpMDDvgJk8G9QWyPjlN-d3pyJp4hBf_Z8gSPHW2Tzy8.a9FneZJZ0vHNdT66vj9JPwoaH-90c4u-nUHmS1n5qXkjwUhFvlr7uYobBw~6d0c298caa94ef27f0ddb2c2e02005c0

Analyst Recommendations on Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences' 2022 Loss Widens, Misses Analysts' Expectations MT
UBS Adjusts Shanghai Junshi Biosciences' Price Target to HK$65.40 From HK$70.90, Keeps at Buy MT
UBS Adjusts Shanghai Junshi Biosciences’ Price Target to HK$70.90 From HK$77.70, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
10.82 CNY
Average target price
22.86 CNY
Spread / Average Target
+111.32%
High Price Target
42.1 CNY
Spread / Highest target
+289.17%
Low Price Target
11.12 CNY
Spread / Lowest Target
+2.78%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Shanghai Junshi Biosciences Co., Ltd.

UBS

Ratings for Shanghai Junshi Biosciences Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 1877 Stock
  4. 8SJ Stock
  5. Consensus Shanghai Junshi Biosciences Co., Ltd.